One-on-One Partnering Breaks All Records
More than 130,000 partnering meeting requests and 25,500+ meetings took place during the 4 days in Chicago...including about 4,900 exhibitor partnering meetings. One-on-One Partnering exceeds all industry records!
Watch the Latest on Partnering »
Rachel King is the first female chair of BIO
King discusses how we can enhance the climate for innovation with communication, strong and helpful FDA, and need to protect financial incentives so we can deliver the innovations.
Watch her Interview »
BIO Exhibition Highlights
More than 1,722 exhibitors and covered 180,000 square feet with 60 state and international pavilions. Exhibitor booth partnering hosted 5,400 meetings, a 25 percent increase over 2012...
Watch Tuesday Highlights »
Forbes 30 Under 30
Keynote speaker Josh Sommer discusses his rare cancer diagnosis and his journey to become the Executive Director of The Chordoma Foundation. He also explains his search for information, insight and connections at BIO...
Watch the Interview »
Connect. Partner. Innovate.
Follow @bioconvention
5/21/2013 - BIOConvention: Read @ScienceBuddies blog recap on the #BIO2013 5K Run: http://t.co/r6b70RQ02q (@AstellasUS donated the registration proceeds to them!)
Read more...5/20/2013 - BIOConvention: Did you see Elvis at the #BIO2013 Monday night Welcome Reception? Here he is, crooning and swiveling: http://t.co/7hMFmJOD22
Read more...
BIO Video Show Daily
Brought to you by
One-on-One Partnering Breaks All Industry Records
Anthony Raeside, Head of Research, Evaluate Pharma
Chris Morrison, EBI, interviews Glen Giovannetti, Ernst & Young
Briggs Morrison, EVP of Global Medicine Development, AstraZeneca
Peter Pellerito, State Policy and University Relations, BIO
Jim Greenwood, President and CEO, BIO
Small Companies Thinking Big: China Tactical Strategies
25,000+ One-on-One Partnering meetings are taking place in Chicago
Bill Hearl, President & CEO - Immunomic Therapeutics
Dave Mead, Director, Business Development, Novozymes Biopharma
Bill Hagstrom
Steven Damon. President & Founder, 4P Therapeutics
Paul Hastings, CEO, OncoMed Pharmaceuticals
Dr. Claudia Roth, President, Vetter Development Service USA
Dr. Trevor Mundel, President Global Health, Gates Foundation
William Waddill, CFO, Oncomed Pharmaceuticals
Governor Jay Nixon, Missouri
Patrick Lucy, Vice President of Business Development, Pfenex
Scott Williams, VP, Men's Health Network
George Vradenburg, USAgainstAlzheimer's
Chris Garabedian, CEO, Sarepta Therapeutics
Briggs Morrison, EVP of Global Medicine Development, AstraZeneca
Jennifer Griffiths, Chief Mission Officer of the Arthritis Foundation.
Dr. Robin Robinson, Director, BARDA
Ana Fadich, VP, Men's Health Network
Medhat Gorgy, President and CEO PYRAMID LABORATORIES
Chris Yochim - AstraZeneca
Dr. Robin Robinson, Director, BARDA
Kathleen Ruddy, CEO St. Baldricks Foundation
Rachel King, CEO, GlycoMimetics (BIO Chair) with Kate Neville (Women in Bio)
Patrick Livney
Rogerio Vivaldi
Alicia Loffler Interview by Sonia Kim
Kathleen Ruddy, CEO St. Baldricks Foundation
Dr. Heather Snyder, Alzheimer's Association
Dr. Richard Mohs, Distinguished Research Fellow, Eli Lilly
Dr. Richard Mohs, Distinguished Research Fellow, Eli Lilly
Dr. Stephen Spielberg, former Deputy Commissioner of the FDA
Adina Mangubat, President and CEO - Sprial Genetics
David Kappos, Former Director, USPTO, Current Partner Cravath, Swaine and Moore, LLP
Show Me the Money: Reimbursement in an ACA World
Jennifer Griffiths, Chief Mission Officer of the Arthritis Foundation.
Tales From the Wild West (Wing): Reflections from White House Chiefs of Staff Featuring John Podesta
BioCentury This Week with janet Woodcock, Kiran Mazumdar-Shaw, Margaret Hamburg, and Francis Collins
Seth Ginsberg, President, Global Healthy Living Foundation
Governor Jay Nixon, Missouri
David Kappos, Former Director, USPTO, Current Partner Cravath, Swaine and Moore, LLP
Neal Carter, President, Okanagan Speciality Fruit
Dr. Stephen Spielberg, former Deputy Commissioner of the FDA
Fred Horne, Minister of Health and Wellness - Alberta
Governor Steve Beshear, Kentucky
BioCentury This Week
International Presence at the 2013 BIO International Convention
Dr. Trevor Mundel, President Global Health, Gates Foundation
Buzz Center: Joseph Damond
Dr. Andrew Powell, CEO, Asia Bio Business
Patricia May, President & CEO, Tembua (in the Minnesota Pavilion)
Small Companies Thinking Big: China Tactical Strategies
Quebec
Chris Morrison, EBI, interviews Glen Giovannetti, Ernst & Young
Joseph Cho, Managing Director, RDPAC
Dr. Claudia Roth, President, Vetter Development Service USA
Thomas Lukaszuk, Minister of Enterprise and Advanced Education, Alberta
One-on-One Partnering Breaks All Industry Records
Rachel King, CEO, GlycoMimetics (BIO Chair) with Kate Neville (Women in Bio)
Exhibitor Hospitality Receptions: Highlights from Tuesday Evening
Peter Pellerito, State Policy and University Relations, BIO
Ashley Anderson, Choose Chicago
Chris Garabedian, CEO, Sarepta Therapeutics
Jim Greenwood, President and CEO, BIO
Medhat Gorgy, President and CEO PYRAMID LABORATORIES
Patricia May, President & CEO, Tembua (in the Minnesota Pavilion)
Jennifer Griffiths, Chief Mission Officer of the Arthritis Foundation.
Ana Fadich, VP, Men's Health Network
Briggs Morrison, EVP of Global Medicine Development, AstraZeneca
Scott Williams, VP, Men's Health Network
Ashley Anderson, Choose Chicago
Peter Pellerito, State Policy and University Relations, BIO
Bill Hearl, President & CEO - Immunomic Therapeutics
International Presence at the 2013 BIO International Convention
Man On Street - Coffee Montage
John Sterling, Editor-In-Chief, GEN
Governor Tom Corbett
Natalie Ng, Winner, International BioGENEius Challenge
Jiho Park
Graham Brookes
Adina Mangubat, President and CEO - Sprial Genetics
Donald Johnston, EVV, AHC Media
VIEW PHOTOS BY DAY
BIOtechNOW DIGITAL DAILY
-
Five Countries, One Goal: Collaboration with Global Impact in the Life Sciences Industry
Publish Date: 5/3/2013 10:50 AM
During the 2013 BIO International Convention, the Massachusetts Life Sciences Center (MLSC) and regions from four other countries launched the new International Collaborative Industry Program (ICIP). The MLSC w...
-
Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality
Publish Date: 4/29/2013 10:46 AM
As biopharmaceutical manufacturers consider the new reality of accountable care organizations (ACOs) and the impact on their businesses, they must be ready to demonstrate the value of their products in ways tha...
-
BioGENEius – From Student Participant to Judge
Publish Date: 4/25/2013 13:52 PM
It’s been two years since I participated as a student in BioGENEius. Last year I presented my work at the White House Science Fair and now I am privileged to attend BioGENEius 2013 as a judge. BioGENEius 2013 i...
Press Releases
See All »
